Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 3Phase 2 3Phase 1/2 1

Status

Active not recruiting 2Terminated 1Completed 1

Sponsor Class

INDUSTRY 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Breast Neoplasms 13Carcinoma, Non-Small-Cell Lung 11Neoplasm Metastasis 7Brain Neoplasms 7Rectal Neoplasms 6Lung Neoplasms 6Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 5Urinary Bladder Neoplasms 4Prostatic Neoplasms 4Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Uterine Cervical Neoplasms 3Pancreatic Neoplasms 3Melanoma 3Glioblastoma 3Colorectal Neoplasms 3Colonic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Inflammatory Breast Neoplasms 2Glioma 2Central Nervous System Neoplasms 2Carcinoma, Ovarian Epithelial 2Adenocarcinoma 2Vaginal Neoplasms 1

Interventions

Gemcitabine 28Cisplatin 26Mitomycin 18BCG Vaccine 12pembrolizumab 9Paclitaxel 8Doxorubicin 7Docetaxel 75-aminolevulinic acid hexyl ester 7apaziquone 6Carboplatin 6vinflunine 5enfortumab vedotin 5atezolizumab 5Vinblastine 5Radiotherapy 5Methotrexate 5Magnetic Resonance Spectroscopy 5Fluorouracil 5Cystectomy 5durvalumab 4Surgical Procedures, Operative 4Nivolumab 4Transurethral Resection of Bladder 3Specimen Handling 3Selenium 3Radiation 3Filgrastim 3Cystoscopy 3BCG Connaught 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Urinary Bladder Neoplasms × Surgical Procedures, Operative × Clear all
NCT04700124 2026-02-05

KEYNOTE-B15

Merck Sharp & Dohme LLC

Phase 3 Completed
808 enrolled
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT03924856 2025-08-28

KEYNOTE-866

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
907 enrolled
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT03924895 2025-08-28

KEYNOTE-905

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
595 enrolled 1 FDA
Genitourinary

Urinary Bladder Neoplasms

NCT00003824 2012-03-09

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

SWOG Cancer Research Network

Phase 3 Terminated
114 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡